| Literature DB >> 28464804 |
Young Ho Yun1,2, Young Ae Kim3, Myung Kyung Lee4, Jin Ah Sim5, Byung-Ho Nam6, Sohee Kim6, Eun Sook Lee3, Dong-Young Noh7, Jae-Young Lim8, Sung Kim9, Si-Young Kim10, Chi-Heum Cho11, Kyung Hae Jung12, Mison Chun13, Soon Nam Lee14, Kyong Hwa Park15, Sohee Park16.
Abstract
BACKGROUND: We aimed to evaluate the potential benefits of the Leadership and Coaching for Health (LEACH) program on physical activity (PA), dietary habits, and distress management in cancer survivors.Entities:
Keywords: Balanced diet; Health coaching; Health partnership; Positive thinking; Regular exercise
Mesh:
Year: 2017 PMID: 28464804 PMCID: PMC5412037 DOI: 10.1186/s12885-017-3290-9
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Flow diagram of participants: recruitment and eligibility screening, randomization, follow-up, and analyses
Baseline characteristics of the patients
| Characteristic | Control group | Intervention group | All participants |
|
|---|---|---|---|---|
| ( | ( | ( | ||
| No. Coaching attendees | 10.63 (6.29) | |||
| Age, years | 51.04 (7.55) | 50.52 (10.21) | 50.68 (9.43) | |
| Sex - no.(%) | ||||
| Male | 18 (25.00) | 24 (17.91) | 42 (20.39) | 0.229 |
| Female | 54 (75.00) | 110 (82.09) | 164 (79.61) | |
| Marital status- no.(%) (missing = 2) | ||||
| Married | 63 (87.50) | 106 (80.30) | 169 (82.84) | 0.193 |
| Widowed/Divorced/separated/single | 9 (12.50) | 26 (19.70) | 35 (17.16) | |
| Education - no.(%) (missing = 2) | ||||
| High-school graduate or less | 39 (54.17) | 66 (50.00) | 105 (51.47) | 0.569 |
| College graduate | 33 (45.83) | 66 (50.00) | 99 (48.53) | |
| Religion - no.(%) (missing = 4) | ||||
| No | 16 (22.86) | 47 (41.17) | 64 (31.19) | 0.063 |
| Yes | 54 (77.14) | 85 (64.39) | 139 (68.81) | |
| Household income –no.(%) (missing = 4) | ||||
| < 300million won | 25 (34.72) | 49 (37.69) | 49 (47.62) | 0.675 |
| ≥ 300million won | 47 (65.28) | 81 (82.38) | 128 (63.37) | |
| Cancer stage (missing = 7) | ||||
| 0 | 2 (2.94) | 3 (2.29) | 5 (2.51) | 0.476 |
| I | 31 (45.59) | 69 (52.67) | 100 (52.67) | |
| II | 28 (41.19) | 38 (29.01) | 66 (33.17) | |
| III | 4 (5.88) | 16 (12.21) | 20 (10.05) | |
| IV | 1 (1.47) | 1 (0.76) | 2 (1.01) | |
| Other (5,6) | 2 (2.94) | 4 (3.05) | 6 (3.02) | |
| Type of cancer | ||||
| Stomach | 17 (23.94) | 34 (25.76) | 51 (25.12) | |
| Lung | 3 (2.80) | 5 (5.20) | 5 (3.79) | |
| Breast | 42 (59.15) | 81 (79,98) | 123 (60.59) | |
| Colorectal | 5 (7.04) | 6 (4.55) | 11 (5.42) | |
| Gynecologic | 4 (5.63) | 5 (3.79) | 9 (4.43) | |
| Other | 0 (0) | 1 (0.76) | 1 (0.49) | |
| Type of treatment (missing = 10) | ||||
| Surgery | 68 (98.55) | 127 (100.00) | 195 (99.49) | 0.174 |
| Radiotherapy | 39 (56.52) | 61 (64.80) | 100 (51.02) | 0.256 |
| Chemotherapy | 43 (62.32) | 76 (59.84) | 119 (60.71) | 0.735 |
| Hormonal therapy | 20 (50.0) | 31 (40.26) | 51 (43.59) | 0.314 |
| Weight, kg (missing = 1) | 56.31 (8.36) | 57.53 (8.72) | 57.10 (8.59) | 0.330 |
| BMI (missing = 1) | 21.70 (2.67) | 22.23 (3.00) | 22.05 (2.89) | 0.213 |
| Hemoglobin (missing = 14) | 13.05 (1.25) | 13.06 (1.22) | 13.05 (1.23) | 0.955 |
| Total Cholesterol-mg/dl (missing = 21) | 173.72 (28.62) | 181.9 (34.60) | 178.96 (11.44) | 0.103 |
| Systolic blood pressure, mm Hg (missing = 87) | 116.33–72.94 | 112.9–72.93 | 117.52–72.94 | 0.462/0.999 |
| Baseline | ||||
| Vegetable intake 5 plates/day, no. (%) | ||||
| Yes | 22 (30.56) | 45 (33.58) | 67 (32.52) | 0.659 |
| No | 50 (69.44) | 89 (66.42) | 139 (67.48) | |
| Total-MET | 27.53 (19.82) | 26.67 (27.50) | 26.97 (25.04) | 0.799 |
| Posttraumatic Growth Inventory | ||||
| Relating to others | 20.83 (6.17) | 21.40 (6.64) | 21.21 6.47) | 0.568 |
| New possibilities | 14.36 (5.10) | 14.61 (4.70) | 14.52 (4.83) | 0.723 |
| Personal strength | 11.28 (4.37) | 11.90 (4.01) | 11.68 (4.14) | 0.308 |
| Spiritual change | 5.07 (3.09) | 4.72 (4.20) | 4.84 (3.08) | 0.444 |
| Appreciation for life | 10.21 (3.18) | 10.46 (2.92) | 10.37 (3.01) | 0.576 |
| Total | 61.78 (18.91) | 63.09 (18.51) | 62.63 (18.61) | 0.631 |
Unless otherwise indicated, values = mean (SD)
MET metabolic equivalent task, BMI body mass index
Primary outcomes over time
| Time point | Intervention group | Control group |
| ||
|---|---|---|---|---|---|
| Total no. | Success no. (%) | Total no. | Success no. (%) | ||
| Baseline | 134 | 47 (35.1) | 72 | 25 (34.7) | 0.960 |
| 3 months | 100 | 44 (44.0) | 55 | 20 (36.4) | 0.356 |
| 12 months | 92 | 42 (45.7) | 50 | 16 (32.0) | 0.114 |
Each time point includes three primary outcomes (MET, PTGI, Vegetable intake 5 plates/day), with two or more defining success
†Chi-square test
Effect of health partnership program
| Unadjusted estimates, mean (SD) | Adjusted analysis for intervention vs usual carea | |||||
|---|---|---|---|---|---|---|
| Intervention group | Control group | Intervention group | Control group |
| ||
| MET/h/day | Baseline | 26.7 (27.5) | 27.5 (19.8) | |||
| 3 months | 27.1 (25.4) | 24.3 (24.6) | 26.2 (2.2) | 23.9 (3.0) | 0.540 | |
| 12 months | 23.5 (23.6) | 22.9 (24.6) | 22.9 (2.3) | 22.8 (3.3) | 0.975 | |
| PTGI-Total | Baseline | 63.1 (18.5) | 61.8 (18.9) | |||
| 3 months | 63.6 (19.3) | 61.2 (18.6) | 62.7 (1.3) | 62.1 (1.7) | 0.791 | |
| 12 months | 66.6 (19.3) | 60.2 (19.1) | 66.3 (1.6) | 61.2 (2.2) |
| |
| Vegetable intake n(%), ≥5 serves/day | Baseline | 45 (33.6) | 22 (30.6) | |||
| 3 months | 52 (42.6) | 27 (40.9) | 33.6 (4.9) | 31.0 (6.3) | 0.819 | |
| 12 months | 41 (36.9) | 26 (42.6) | 31.0 (5.4) | 37.3 (6.7) | 0.413 | |
| Leadership | Baseline | 121.3 (21.2) | 120.1 (20.8) | |||
| 3 months | 125.0 (21.7) | 121.6 (20.2) | 123.1 (1.3) | 121.8 (1.9) | 0.552 | |
| 12 months | 127.7 (22.1) | 122.8 (20.6) | 125.4 (1.6) | 123.3 (2.2) | 0.433 | |
| HADS | ||||||
| Anxiety | Baseline | 5.7 (3.4) | 5.9 (3.1) | |||
| 3 months | 5.0 (3.0) | 6.1 (3.1) | 5.2 (0.2) | 6.0 (0.3) |
| |
| 12 months | 5.1 (3.0) | 5.8 (2.9) | 5.2 (0.3) | 5.7 (0.4) | 0.228 | |
| Depression | Baseline | 6.4 (3.5) | 6.1 (3.1) | |||
| 3 months | 5.5 (3.3) | 5.4 (2.8) | 5.6 (0.2) | 5.6 (0.3) | 0.986 | |
| 12 months | 5.4 (3.4) | 5.6 (3.1) | 5.3 (0.3) | 5.7 (0.4) | 0.428 | |
| EORTC QLQ-C30 | ||||||
| Functional scales | ||||||
| Global health status | Baseline | 64.5 (19.9) | 63.4 (18.7) | |||
| 3 months | 67.7 (18.7) | 65.7 (17.5) | 67.0 (1.6) | 66.0 (2.3) | 0.705 | |
| 12 months | 70.1 (17.1) | 65.3 (17.9) | 69.0 (1.6) | 66.0 (2.2) | 0.269 | |
| Physical functioning | Baseline | 78.6 (13.5) | 77.9 (11.1) | |||
| 3 months | 80.0 (12.1) | 78.4 (12.0) | 79.4 (0.9) | 79.3 (1.3) | 0.942 | |
| 12 months | 82.9 (13.1) | 78.2 (12.4) | 81.9 (1.2) | 78.7 (1.6) | 0.123 | |
| Role functioning | Baseline | 79.4 (21.4) | 77.9 (19.8) | |||
| 3 months | 80.9 (18.1) | 77.3 (18.4) | 80.3 (1.5) | 78.5 (2.2) | 0.497 | |
| 12 months | 82.7 (19.8) | 79.9 (18.9) | 80.9 (1.8) | 81.1 (2.4) | 0.958 | |
| Emotional functioning | Baseline | 76.8 (19.4) | 73.0 (23.0) | |||
| 3 months | 78.0 (19.1) | 74.5 (16.5) | 76.7 (1.5) | 75.3 (2.2) | 0.602 | |
| 12 months | 78.0 (19.9) | 75.9 (18.3) | 76.2 (1.9) | 77.7 (2.4) | 0.625 | |
| Cognitive functioning | Baseline | 76.7 (19.9) | 72.6 (20.9) | |||
| 3 months | 80.1 (17.2) | 72.5 (20.2) | 77.6 (1.4) | 75.1 (2.4) | 0.322 | |
| 12 months | 78.1 (14.9) | 76.5 (19.2) | 76.8 (1.6) | 78.4 (2.1) | 0.552 | |
| Social functioning | Baseline | 75.8 (26.8) | 73.1 (23.4) | |||
| 3 months | 85.4 (19.3) | 76.3 (20.2) | 84.8 (1.8) | 77.4 (2.5) | 0.018 | |
| 12 months | 85.3 (19.5) | 78.2 (22.4) | 84.8 (2.2) | 79.0 (2.9) | 0.123 | |
| Symptom scales | ||||||
| Fatigue | Baseline | 38.6 (20.9) | 40.8 (21.6) | |||
| 3 months | 33.5 (17.8) | 38.1 (17.7) | 34.3 (1.5) | 37.6 (2.2) | 0.214 | |
| 12 months | 33.8 (16.1) | 42.4 (21.4) | 34.8 (1.6) | 41.9 (2.1) |
| |
| Nausea/vomiting | Baseline | 4.6 (10.0) | 4.2 (10.6) | |||
| 3 months | 5.7 (10.6) | 5.3 (9.8) | 5.6 (0.9) | 6.2 (1.3) | 0.733 | |
| 12 months | 6.4 (14.5) | 7.8 (15.3) | 6.5 (1.6) | 7.7 (2.1) | 0.660 | |
| Pain | Baseline | 15.4 (19.2) | 21.4 (19.0) | |||
| 3 months | 11.9 (16.0) | 19.6 (19.6) | 13.6 (1.5) | 17.4 (2.1) | 0.146 | |
| 12 months | 13.1 (17.6) | 19.7 (21.4) | 15.5 (1.8) | 16.2 (2.3) | 0.810 | |
| Dyspnea | Baseline | 11.9 (19.9) | 19.4 (21.0) | |||
| 3 months | 8.2 (15.9) | 13.7 (16.6) | 10.3 (1.3) | 11.3 (1.9) | 0.668 | |
| 12 months | 10.6 (19.5) | 13.6 (17.9) | 12.1 (2.0) | 11.3 (2.6) | 0.797 | |
| Insomnia | Baseline | 28.8 (30.0) | 30.3 (28.9) | |||
| 3 months | 24.1 (24.50 | 26.7 (26.9) | 25.0 (2.1) | 25.7 (3.1) | 0.850 | |
| 12 months | 26.2 (27.9) | 32.0 (27.2) | 27.6 (2.5) | 29.1 (3.4) | 0.732 | |
| Appetite loss | Baseline | 12.8 (20.9) | 15.4 (24.8) | |||
| 3 months | 10.7 (17.6) | 17.3 (23.6) | 11.3 (1.8) | 17.7 (2.6) | 0.048 | |
| 12 months | 11.6 (17.6) | 13.6 (20.3) | 12.1 (2.0) | 13.7 (2.6) | 0.631 | |
| Constipation | Baseline | 16.9 (26.7) | 18.9 (24.1) | |||
| 3 months | 14.7 (23.3) | 16.3 (21.6) | 16.5 (1.8) | 16.0 (2.7) | 0.882 | |
| 12 months | 12.6 (18.1) | 17.7 (20.5) | 19.5 (2.2) | 16.5 (2.9) | 0.414 | |
| Diarrhea | Baseline | 13.8 (20.7) | 11.4 (18.8) | |||
| 3 months | 12.6 (18.1) | 14.0 (17.9) | 19.8 (4.1) | 10.0 (5.4) | 0.151 | |
| 12 months | 20.5 (45.6) | 9.5 (20.4) | 11.9 (1.5) | 15.3 (2.2) | 0.211 | |
| Financial Difficulties | Baseline | 20.3 (28.6) | 23.4 (26.0) | |||
| 3 months | 15.5 (25.5) | 26.8 (37.1) | 17.4 (2.6) | 27.0 (3.7) |
| |
| 12 months | 18.9 (26.6) | 20.4 (27.9) | 18.9 (2.5) | 19.3 (3.3) | 0.920 | |
| The MOS-SSS | Baseline | 65.6 (20.9) | 65.6 (20.6) | |||
| 3 months | 66.3 (21.1) | 67.9 (19.3) | 66.9 (1.4) | 65.7 (2.0) | 0.621 | |
| 12 months | 66.6 (21.1) | 68.0 (19.7) | 67.1 (1.7) | 65.3 (2.4) | 0.535 | |
| Health Behavior | Baseline | 4.9 (3.1) | 5.2 (2.7) | |||
| 3 months | 6.4 (2.7) | 5.5 (3.0) | 6.9 (0.3) | 6.2 (0.4) | 0.147 | |
| 12 months | 7.0 (2.8) | 6.3 (2.7) | 6.3 (0.2) | 5.3 (0.3) |
| |
| IES-R | Baseline | 2.3 (0.8) | 2.5 (0.7) | |||
| 3 months | 2.2 (0.7) | 2.2 (0.7) | 2.3 (0.1) | 2.2 (0.1) | 0.759 | |
| 12 months | 2.1 (0.7) | 2.3 (0.8) | 2.1 (0.1) | 2.3 (0.1) |
| |
aAdjusted baseline value with a statistical power of 80% and an effect size of 0.3 by a two-sided t test at the 0.05 α level was used
*p < 0.10 with bold
**p < 0.05 with bold
1)ANCOVA
MET Metabolic Equivalent Task, PTGI Post-traumatic Growth Inventory, HADS Hospital and Anxiety Scale, EROTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, MOS-SSS Medical Outcomes Study Social Support Survey, IES-R Impact of Event Scale--Revised